FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40143811000001109: Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2051921000001113 Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2051941000001115 Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction special true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Is a Trastuzumab 126mg/250ml in Sodium chloride 0.9% infusion bags true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has specific active ingredient Trastuzumab true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has dispensed dose form Infusion true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) 1 bag Has AMP True Trastuzumab (Ontruzant) 126mg/250ml in Sodium chloride 0.9% infusion bags (Special Order) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start